Gonadorelin is a gonadotropin-releasing hormone agonist which is used in fertility medicine and to treat amenorrhea and hypogonadism.

How Can You Benefit From Gonadorelin?

Gonadorelin helps increase sperm count and volume in men and increase testosterone production. It also helps with testicular atrophy, otherwise known as testicular shrinkage.

What Are The Benefits of Gonadorelin?

  • Prevents testicular shrinkage
  • Increases LH
  • Helps to boost libido
  • Regulates and normalizes your testosterone levels

Other Uses

Gonadorelin is also used by women who are missing menstrual periods due to low levels of gonadotropin-releasing hormone (GnRH).

It may be used as part of female infertility treatment. This medication provides GnRH that the body needs for the growth and release of mature eggs from the ovaries (ovulation).

What is the most important information I should know about gonadorelin?

Before using gonadorelin, tell your doctor if you have any other medical conditions or if you take any medications, including herbal products. You may not be able to take gonadorelin, or you may require a dosage adjustment or special monitoring.


Gonadotropin-releasing hormone (GnRH), a decapeptide synthesized and released by the hypothalamus, regulates production and release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by the adenohypophysis.

Parenterally administered GnRH was initially used diagnostically as a test of adenohypophyseal reserve of LH and FSH.

Subsequently, native GnRH was used therapeutically to treat hypothalamic hypogonadal and infertility states in both men and women.

Because of the low potency and short half-life of native GnRH, long-acting, potent analogs have been developed that suppress secretion of native pituitary gonadotropins, resulting in medical gonadectomy.

When administered parenterally and, more recently, intranasally, these compounds are useful in the management of prostate and breast carcinoma, endometriosis and uterine leiomyomata, precocious puberty and nontumorous ovarian hyperandrogenic syndromes.